Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference30 articles.
1. Cancer Statistics, 2006;Jemal;CA Cancer J Clin,2006
2. Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trials;Mincey;Oncologist,2002
3. Current and future status of adjuvant therapy for breast cancer;Coleman;Cancer,2003
4. A high incidence of vertebral fracture in women with breast cancer;Kanis;Br J Cancer,1999
5. Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study;Utz;J Chronic Dis,1987
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial;PLOS ONE;2024-04-18
2. Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study;Therapeutic Advances in Medical Oncology;2024-01
3. Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: implications for bone health;2023-11-10
4. DXA assessment and fracture prevention in hormone positive breast cancer patients after treatment initiation with aromatase inhibitors: A registry-based cohort study;Journal of Bone Oncology;2023-10
5. Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer;Breast Cancer: Targets and Therapy;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3